Javan Balegh Marand A, et al. Differences in the Urinary Microbiome of Patients with

Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements.

Damgaard, R, et al. HPV type-specific likelihood of regression in women undergoing

active surveillance for CIN2 HPV16.

Evans T, et al. Assessment of CD8+ T-cell mediated immunity in an influenza A/H3N2 human
challenge mode.

Aitken CA, et al. Sociodemographic Characteristics and Screening Outcomes of Women
Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A
Population-Based Study.

Armando F, et al. SARS-CoV-2 Omicron variant causes mild pathology in the upper and

lower respiratory tract of hamsters.

Mykytyn AZ, et al. Antigenic mapping of emerging SARS-CoV-2 omicron

variants BM.1.1.1, BQ.1.1, and XBB.1.

D’Souza G, et al. Prevalence of oral and blood oncogenic human papillomavirus biomarkers

among an enriched screening population: Baseline results of the MOUTH study.

Vink FJ, et al. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18
Genotyping in HPV-Positive Women Under the Age of 30 Years.

Prins MLM, et al. Viral clearance, pharmacokinetics and tolerability of

ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.

Somogyi E, et al. T cell immunity ameliorates COVID-19 disease severity and provides

post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters.

Aknouch I, et al. Human milk inhibits some enveloped virus infections,

including SARS-CoV-2, in an intestinal model.

Armando F, et al. SARS-CoV-2 Omicron variant causes mild pathology

in the upper and lower respiratory tract of hamsters.

Bibby DC, et al. Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition Assays.

Damgaard RK, et al. Performance of HPV E4 and p16INK4a biomarkers in

predicting regression of cervical intraepithelial neoplasia grade 2

(CIN2): protocol for a historical cohort study.

de Geus V, et al. Identifying Molecular Changes in Early Cervical Cancer

Samples of Patients That Developed Metastasis.

Du W, et al. An ACE2-blocking antibody confers broad neutralization and

protection against Omicron and other SARS-CoV-2 variants of concern.

Ghorzang E, et al. HPV type-specific distribution among family members

and linen in households of cutaneous wart patients.

Hammer A, et al. Evidence of latent HPV infection in older Danish

women with a previous history of cervical dysplasia.

King CHS 4th, et al. Communicating regulatory high-throughput

sequencing data using BioCompute Objects.

Mena M, et al. Concordance of p16^INK4a and E6*I mRNA

among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas

from the ICO International Study.

Niemeyer-van der Kolk T, et al. Topical antimicrobial peptide omiganan recovers

cutaneous dysbiosis but does not improve clinical symptoms in patients with

mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.

Pagan L, et al. Results of a randomized, placebo-controlled, first-in-human

trial of topical CY-002 in patients with cutaneous warts.

Pedersen H, et al. Clinical Performanceof the Full Genotyping Agena

MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4

Framework. J Mol Diagn.

Sierra MS, et al. Analysis of cervical HPV infections among unvaccinated

young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial.

Tewari SR, et al. Association of Plasma Circulating Tumor HPV DNA With

HPV-Related Oropharynx Cancer. JAMA Otolaryngol Head Neck Surg.

van den Tweel MM, et al. The relationship between vaginal pH and

bacterial vaginosis as diagnosed using qPCR in an asymptomatic subfertile population.

Verhoef L, et al. Performance of DNA methylation analysis of ASCL1,

LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women:

Results from a Dutch primary HPV- based screening cohort.

Wahid R, et al. Evaluating stability of attenuated Sabin and two novel

type 2 oral poliovirus vaccines in children.

Wahid R, et al. Genetic and phenotypic stability of poliovirus shed from

infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines

in Panama: an analysis of two clinical trials.

Zarn KE, et al. Stenoparib, an inhibitor of cellular poly (ADP-ribose)

polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants.

Zwittink RD, et al. The vaginal microbiota in the course of bacterial vaginosis treatment.

Du W, et al. An ACE2-blocking antibody confers broad neutralization and

protection against Omicron and other SARS-CoV-2 variants of concern.

Bibby DC, et al. Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition Assays.

Armando F, et al. SARS-CoV-2 Omicron variant causes mild pathology

in the upper and lower respiratory tract of hamsters.

Hu SY, et al.Performance of Cervical Screening a Decade Following

HPV Vaccination: The Costa Rica Vaccine Trial.

Cabanski M, et al. Identifying Molecular Changes in Early Cervical Cancer Flow cytometric

method transfer: Recommendations for best practice.

Bhatia R, et al. Evaluation of HarmoniaHPV test for detection of clinically

significant Human Papillomavirus infection using the VALGENT framework.

Bonde J, et al. Methylation markers FAM19A4 and miR124-2 as triage

strategy for primary human papillomavirus screen positive women: A large European multicenter study.

Dasgupta S, et al. Relationship of human papillomavirus with seborrheic

keratosis of the female genital tract – a case-series and literature review.

Gosens KCM, et al. HPV vaccination to prevent recurrence of

anal intraepithelial neoplasia in HIV+MSM.

Liu Y, et al. Transient CRISPR-Cas Treatment Can Prevent Reactivation of

HIV-1 Replication in a Latently Infected T-Cell Line.

Watterson D, et al. Preclinical development of a molecular clamp-stabilised

subunit vaccine for severe acute respiratory syndrome coronavirus 2.

McMillan CLD, et al. Development of molecular clamp stabilized hemagglutinin

vaccines for Influenza A viruses.

Ryu DK, et al. The in vitro and in vivo efficacy of CT-P59 against Gamma,

Delta and its associated variants of SARS-CoV-2.

Shim TN, et al. The prevalence of human leucocyte antigen and human papillomavirus

DNA in penile intraepithelial neoplasia in England 2011-2012.

Sierra MS, et al. Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18

Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated

Against HPV-16/18 in the Costa Rica Vaccine Trial.

Tota JE, et al. Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus

(HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the

Costa Rica Vaccine Trial and the PATRICIA Study.

van den Munckhof EHA, et al. Developing an algorithm for the diagnosis of abnormal vaginal

discharge in a dutch clinical setting: a pilot study.

van der Zee RP, et al. Characterisation of anal intraepithelial neoplasia and anal cancer in HIV-positive

men by immunohistochemical markers p16, Ki-67, HPV-E4 and DNA methylation markers.

van der Zee RP, et al.  Cancer Risk Stratification of Anal Intraepithelial Neoplasia

in Human Immunodeficiency Virus-Positive Men by Validated Methylation

Markers Associated With Progression to Cancer.

Vos LMet al. Lower respiratory tract infection in the community:

associations between viral aetiology and illness course.

McMillan CLD, et al.  Development of molecular clamp stabilized

hemagglutinin vaccines for Influenza A viruses.

Watchorn RE, et al. Balanopreputial sac and urine microbiota in

patients with male genital lichen sclerosus.

Zwittink RD, et al. The vaginal microbiota in the course of bacterial vaginosis treatment.

Mykytyn AZ, Let al. Susceptibility of rabbits to SARS-CoV-2.

Ryu DK, Song Ret al. Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.

Wahid R, et al. Assessment of genetic changes and neurovirulence of

shed Sabin and novel type 2 oral polio vaccine viruses.

Stadlbauer D, et al. AS03-adjuvanted H7N9 inactivated split virion vaccines

induce cross-reactive and protective responses in ferrets.

Konz JO, et al. Evaluation and validation of next-generation sequencing

to support lot release for a novel type 2 oral poliovirus vaccine.

van der Lubbe JEM, et al. Ad26.COV2.S protects Syrian hamsters against G614 spike variant

SARS-CoV-2 and does not enhance respiratory disease.

Watterson D, et al. Preclinical development of a molecular clamp-stabilised

subunit vaccine for severe acute respiratory syndrome coronavirus 2.

van Keulen BJ, et al. Human Milk from Previously COVID-19-Infected Mothers:

The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity.